Skip to main content

Adagrasib



General

Brand Names: U.S.

  • Krazati

Indications

Use: Labeled Indications

Colorectal cancer, locally advanced or metastatic, KRAS G12C mutated: Treatment (in combination with cetuximab) of KRAS G12Cmutated ...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×